Comcast Holdings Corp (CCZ)vsJanus Living, Inc. (JAN)
CCZ
Comcast Holdings Corp
$64.67
0.00%
REAL ESTATE · Cap: $61.13B
JAN
Janus Living, Inc.
$30.92
+0.36%
REAL ESTATE · Cap: $9.59B
Smart Verdict
WallStSmart Research — data-driven comparison
JAN leads profitability with a 1.8% profit margin vs 0.0%. JAN earns a higher WallStSmart Score of 35/100 (F).
CCZ
Avoid21
out of 100
Grade: F
JAN
Avoid35
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Generating 5.2B in free cash flow
Revenue surging 45.4% year-over-year
Reasonable price relative to book value
Areas to Watch
0.0% revenue growth
0.0% earnings growth
0.0% margin — thin
Operating margin of 0.0%
0.0% earnings growth
Distress zone — elevated risk
1.8% margin — thin
ROE of -0.1% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : CCZ
The strongest argument for CCZ centers on Market Cap, Free Cash Flow.
Bull Case : JAN
The strongest argument for JAN centers on Revenue Growth, Price/Book. Revenue growth of 45.4% demonstrates continued momentum.
Bear Case : CCZ
The primary concerns for CCZ are Revenue Growth, EPS Growth, Profit Margin. A P/E of 55.2x leaves little room for execution misses.
Bear Case : JAN
The primary concerns for JAN are EPS Growth, Altman Z-Score, Profit Margin. Thin 1.8% margins leave little buffer for downturns.
Key Dynamics to Monitor
CCZ profiles as a value stock while JAN is a hypergrowth play — different risk/reward profiles.
JAN is growing revenue faster at 45.4% — sustainability is the question.
CCZ generates stronger free cash flow (5.2B), providing more financial flexibility.
Monitor REIT - RESIDENTIAL industry trends, competitive dynamics, and regulatory changes.
Bottom Line
JAN scores higher overall (35/100 vs 21/100) and 45.4% revenue growth. Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Janus Living, Inc.
REAL ESTATE · REIT - RESIDENTIAL · USA
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for pain management. The company is headquartered in Las Vegas, Nevada.
Compare with Other REIT - RESIDENTIAL Stocks
Want to dig deeper into these stocks?